💉 RETATRUTIDE 120 MG KIT – 60 MG / VIAL – 2 VIALS – ZPHC PHARMA

💉 Product Type

Investigational Triple Receptor Agonist Peptide / Lyophilized Injectable

💉 Active Ingredient

Retatrutide

• Strength: 60 MG / Vial

• Total Content: 120 MG

• Presentation: 2 Vials

• Form: Lyophilized peptide powder

💉 Description

RETATRUTIDE 120 MG KIT by ZPHC PHARMA contains a total of 120 MG of Retatrutide, supplied as 2 separate vials of 60 MG each.

Retatrutide is an investigational peptide designed to activate three metabolic hormone receptors simultaneously:

• GLP-1 (Glucagon-Like Peptide-1)

• GIP (Glucose-Dependent Insulinotropic Polypeptide)

• Glucagon Receptor

This triple-action mechanism has been investigated for its effects on appetite regulation, body weight, glucose metabolism, energy expenditure, and fat metabolism.

Retatrutide remains an investigational compound and is not an approved treatment for general use.

⚙️ Mechanism of Action

GLP-1 Receptor

Supports pathways involved in appetite regulation, glucose control, and insulin secretion.

GIP Receptor

Influences insulin-related metabolic signaling and energy metabolism.

Glucagon Receptor

Promotes pathways associated with energy expenditure and lipid metabolism.

Combined Activity

The simultaneous activation of these three receptors provides a multi-pathway approach to metabolic regulation and has been investigated extensively in clinical research.

🔬 Research Areas

✅ Appetite and satiety regulation

✅ Body-weight management research

✅ Glucose and metabolic regulation

✅ Energy expenditure

✅ Fat metabolism

✅ Insulin and metabolic signaling

⚠️ Possible Adverse Effects

Potential adverse effects associated with retatrutide research include:

• Nausea

• Vomiting

• Diarrhea or constipation

• Reduced appetite

• Abdominal discomfort

• Injection-site reactions

• Changes in blood glucose

Long-term safety and the appropriate clinical use of retatrutide continue to be evaluated.

❄️ Storage & Handling

• Store according to the manufacturer's specified conditions.

• If supplied as a lyophilized preparation, appropriate reconstitution is required before administration.

• Protect from excessive heat and light.

• Do not use if the vial appears damaged or contaminated.

📦 Technical Summary